Loading clinical trials...
Loading clinical trials...
The aim of this study is the safety and efficacy of cryosurgery plus NK immunotherapy to advanced breast cancer.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fuda Cancer Hospital, Guangzhou
Collaborators
NCT06799065 · Advanced Solid Tumors, Breast Cancer Recurrent, and more
NCT06659146 · Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, and more
NCT05592938 · Breast Cancer, Breast Cancer Recurrent
NCT06683404 · Breast Cancer, Breast Cancer Metastatic, and more
NCT02915445 · Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M), Breast Cancer Recurrent, and more
Cancer Institute in Fuda cancer hospital
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions